A previous publication suggests modification by PLS3 only occurs in mild SMA, in which a low dose of ASO directed against ISS-N1 was administered to the Taiwanese SMA mice to elevate SMN levels and create a milder phenotype [207]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.